Does DUPILUMAB Cause Gait inability? 373 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 373 reports of Gait inability have been filed in association with DUPILUMAB (Dupixent). This represents 0.1% of all adverse event reports for DUPILUMAB.
373
Reports of Gait inability with DUPILUMAB
0.1%
of all DUPILUMAB reports
3
Deaths
82
Hospitalizations
How Dangerous Is Gait inability From DUPILUMAB?
Of the 373 reports, 3 (0.8%) resulted in death, 82 (22.0%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 373 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which DUPILUMAB Alternatives Have Lower Gait inability Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE